Tofacitinib tablets, a medicine approved to treat rheumatoid and psoriatic arthritis, may work for lessening signs and symptoms of arthritis and skin rash in people with systemic lupus erythematosus (SLE), a…
News
Michigan Medicine researchers were granted up to $10.2 million by the Autoimmunity Centers of Excellence (ACE) to develop new projects seeking treatments for autoimmune diseases including lupus. In particular, the team from the University of Michigan’s academic medical center is focused on exploring the relationship between molecular targets…
In observance of World Lupus Day and Lupus Awareness Month, Aurinia Pharmaceuticals has announced disease awareness and educational initiatives aimed at supporting patients with lupus nephritis, a serious complication of systemic lupus erythematosus (SLE). World Lupus Day was May 10, and Lupus Awareness Month is marked…
A comprehensive report co-led by pharmaceutical company GSK underscores the need to enhance care for those living with lupus, and to raise awareness about the disease. The release of the report, titled “A Vision for Lupus,” was timed to World Lupus Day on May 10. Coordinated by…
A survey found that 63 percent of American respondents either had never heard of the autoimmune disease lupus, or knew little about it, the Lupus Foundation of America (LFA) announced during Lupus Awareness Month in May. Results of the Lupus Awareness Study call for better understanding of…
At the 2019 annual meeting of the Childhood Arthritis and Rheumatology Research Alliance (CARRA), leaders from the Lupus Foundation of America (LFA) joined other experts in offering insights into critical needs in childhood lupus. Held in Louisville, Ky. in April, the event focused on the latest advances…
Mallinckrodt Pharmaceuticals has completed enrollment for its Phase 4 clinical trial evaluating the safety and effectiveness of H.P. Acthar Gel (repository corticotropin injection) in patients with persistently active systemic lupus erythematosus (SLE). The company expects the first results to be available by early 2020. “I am delighted that enrollment is completed, and look forward…
The U.S. Food and Drug Administration (FDA) has approved, under priority review, the use of Benlysta (belimumab) for the treatment of children age 5 and older with systemic lupus erythematosus (SLE). Benlysta is a monoclonal human antibody designed to bind and block the activity of the B-lymphocyte…
When it comes to autoimmune disease, diet and lifestyle play an equal role in management and quality of life. It’s important to remember that every day is a new day, and some days will be easier and others more challenging. To navigate the ups and…
Systemic lupus erythematosus (SLE) patients are a higher risk for severe herpes simplex virus (HSV) infection, but younger age seems to be a protective factor, a study from Taiwan suggests. The research also highlights that adults (patients older than 18 ), those with a history of herpes infection, those who…
Recent Posts
- Experimental skin lupus therapy dropped after trial misses main goal
- When we’re too sick to work, but not sick enough for disability
- Embracing an earworm song can benefit those of us with lupus
- Alliance awards over $2M for lifestyle intervention studies in lupus
- Understanding the grief of chronic illness has made me more self-aware